PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723113. A total of 36 filers reported holding PEAR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,167 | -87.2% | 166,666 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $24,817 | -11.4% | 166,666 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $28,000 | +27.3% | 166,666 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $22,000 | -83.3% | 166,666 | 0.0% | 0.00% | -66.7% |
| Q1 2022 | $132,000 | +32.0% | 166,666 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $100,000 | – | 166,666 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kingstown Capital | 200,000 | $158,000 | 0.24% |
| Telemetry Investments, L.L.C. | 85,742 | $68,000 | 0.11% |
| LMR Partners LLP | 1,320,835 | $6,670,000 | 0.08% |
| Arena Investors LP | 126,122 | $100,000 | 0.07% |
| DIFESA CAPITAL MANAGEMENT, LP | 150,000 | $119,000 | 0.06% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,783,495 | $1,413,000 | 0.03% |
| Silver Rock Financial LP | 188,505 | $149,000 | 0.03% |
| ANGELO GORDON & CO., L.P. | 33,332 | $168,000 | 0.02% |
| MYDA Advisors LLC | 57,162 | $45,000 | 0.02% |
| P SCHOENFELD ASSET MANAGEMENT LP | 477,602 | $378,000 | 0.02% |